Mercedes Rodríguez-Calvillo

Mercedes Rodríguez-Calvillo

Auto-generated profile, based on publicly available information

Mercedes Rodríguez-Calvillo

Lymphoproliferative Group, Health Research Institute Navarra (IDISNA), Pamplona, Navarra, Spain

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
CPCarlos Panizo
Carlos Panizo
MPMarta Pérez-Salazar
Marta Pérez-Salazar
MBMaurizio Bendandi
Maurizio Bendandi
MRMercedes Rodríguez-Calvillo
Mercedes Rodríguez-Calvillo
JBJosé Francisco Boán
José Francisco Boán
EREduardo Rocha
Eduardo Rocha
Given its obvious prognostic implications, the correct interpretation of the significance of any residual mediastinal mass following Hodgkin's disease (HD) treatment keeps maintaining its paramount importance. In this respect, 18F-fluorodeoxyglucose positron emission tomography (PET) is proving very effective for both active disease detection and relapse prediction. Twenty-nine consecutive HD patients, in whom computed tomography (CT) scan performed after therapy completion had documented a residual mediatinal mass of at least 2 cm, prospectively entered the study and underwent PET within 1 week from CT scan. With a median follow-up of 28 months from PET execution, no relapse was recorded among the 17 patients presenting with a negative PET. On the contrary, 9 of the 12 patients presenting with a positive PET relapsed/progressed within one year from PET execution. PET's negative and positive predictive values at 1 year were 100% and 75%, respectively. A negative PET seems to possibly exclude relapse in HD patient with a residual mediastinal mass. On the contrary, a positive PET result indicates a significantly higher risk of relapse. However, due to possible false positive results, a closer follow-up for all and a pathologic study in few selected patients is warranted.

1 May 2004
Verified
Journal Article
Closed access
NZNatalia Zabalegui
Natalia Zabalegui
ACAscensión López-Díaz De Cerio
Ascensión López-Díaz De Cerio
SISusana Inogés
Susana Inogés
MRMercedes Rodríguez-Calvillo
Mercedes Rodríguez-Calvillo
JPJavier Pérez-Calvo
Javier Pérez-Calvo
MBMaurizio Bendandi
Maurizio Bendandi


1 December 2003
Verified
Closed access
SISusana Inogés
Susana Inogés
MRMercedes Rodríguez-Calvillo
Mercedes Rodríguez-Calvillo
ACAscensión López-Díaz De Cerio
Ascensión López-Díaz De Cerio
NZNatalia Zabalegui
Natalia Zabalegui
JPJavier Pérez-Calvo
Javier Pérez-Calvo
MBMaurizio Bendandi
Maurizio Bendandi